PubMed

Tailoring iron chelation by iron intake and serum ferritin: prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

Cappellini MD, Porter J, El-Beshlawy A, Li CK, Seymour JF, Elalfy M, Gattermann N, Giraudier S, Lee JW, Chan LL, Lin KH, Rose C, Taher A, Thein SL, Viprakasit V, Habr D, Domokos G, Roubert B, Kattamis A; on behalf of the EPIC study investigators.

Haematologica. 2009 Nov 30. [Epub ahead of print]PMID: 19951979 [PubMed - as supplied by publisher]Related articlesFree article

The role of ancestim (recombinant human stem-cell factor, rhSCF) in hematopoietic stem cell mobilization and hematopoietic reconstitution.

Herbert KE, Prince HM, Ritchie DS, Seymour JF.

Expert Opin Biol Ther. 2009 Dec 1. [Epub ahead of print]PMID: 19947895 [PubMed - as supplied by publisher]Related articles

Hematology: Follicular lymphoma: maintenance therapy is (often) indicated.

Seymour JF.

Nat Rev Clin Oncol. 2009 Nov;6(11):624-6. No abstract available. PMID: 19861993 [PubMed - in process]Related articles

Progress in primary CNS lymphoma.

O'Brien PC, Seymour JF.

Lancet. 2009 Oct 31;374(9700):1477-8. Epub 2009 Sep 18. Review. No abstract available. PMID: 19767091 [PubMed - indexed for MEDLINE]Related articles

5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen.

O'Brien S, Moore JO, Boyd TE, Larratt LM, Skotnicki AB, Koziner B, Chanan-Khan AA, Seymour JF, Gribben J, Itri LM, Rai KR.

J Clin Oncol. 2009 Nov 1;27(31):5208-12. Epub 2009 Sep 8.PMID: 19738118 [PubMed - indexed for MEDLINE]Related articles

Mantle cell lymphoma with central nervous system involvement: frequency and clinical features.

Gill S, Herbert KE, Prince HM, Wolf MM, Wirth A, Ryan G, Carney DA, Ritchie DS, Davies JM, Seymour JF.

Br J Haematol. 2009 Oct;147(1):83-8. Epub 2009 Aug 19.PMID: 19694718 [PubMed - in process]Related articles

The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia.

Mason KD, Khaw SL, Rayeroux KC, Chew E, Lee EF, Fairlie WD, Grigg AP, Seymour JF, Szer J, Huang DC, Roberts AW.

Leukemia. 2009 Nov;23(11):2034-41. Epub 2009 Jul 30.PMID: 19641525 [PubMed - in process]Related articles

Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic?

Peinert S, Carney D, Prince HM, Januszewicz EH, Seymour JF.

Br J Haematol. 2009 Sep;146(6):685-6. Epub 2009 Jul 23. No abstract available. PMID: 19638019 [PubMed - in process]Related articles

The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy.

Gill S, Carney D, Ritchie D, Wolf M, Westerman D, Prince HM, Januszewicz H, Seymour JF.

Ann Oncol. 2009 Jul 22. [Epub ahead of print]PMID: 19625344 [PubMed - as supplied by publisher]Related articles

Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group.

Martinelli G, Ryan G, Seymour JF, Nassi L, Steffanoni S, Alietti A, Calabrese L, Pruneri G, Santoro L, Kuper-Hommel M, Tsang R, Zinzani PL, Taghian A, Zucca E, Cavalli F.

Ann Oncol. 2009 Dec;20(12):1993-9. Epub 2009 Jul 1.PMID: 19570964 [PubMed - in process]Related articles

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.

Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN, Furman RR, Vose JM, Zelenetz AD, Mamtani R, Raisch DW, Dorshimer GW, Rosen ST, Muro K, Gottardi-Littell NR, Talley RL, Sartor O, Green D, Major EO, Bennett CL.

Blood. 2009 May 14;113(20):4834-40. Epub 2009 Mar 5.PMID: 19264918 [PubMed - indexed for MEDLINE]Related articles

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.

Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR; International Vidaza High-Risk MDS Survival Study Group.

Lancet Oncol. 2009 Mar;10(3):223-32. Epub 2009 Feb 21.PMID: 19230772 [PubMed - indexed for MEDLINE]Related articles

Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.

Dickinson M, Prince HM, Kirsa S, Zannettino A, Gibbs SD, Mileshkin L, O'Grady J, Seymour JF, Szer J, Horvath N, Joshua DE.

Intern Med J. 2009 May;39(5):304-16. Epub 2008 Nov 3.PMID: 19220531 [PubMed - in process]Related articles

Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab.

Eve HE, Seymour JF, Rule SA.

Leuk Lymphoma. 2009 Mar;50(3):463-5. No abstract available. PMID: 19197732 [PubMed - indexed for MEDLINE]Related articles

Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study.

Eve HE, Linch D, Qian W, Ross M, Seymour JF, Smith P, Stevens L, Rule SA.

Leuk Lymphoma. 2009 Feb;50(2):211-5.PMID: 19197729 [PubMed - indexed for MEDLINE]Related articles

Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma.

Peinert S, Kamel S, Seymour JF, Prince HM.

Leuk Lymphoma. 2009 Feb;50(2):303-5. No abstract available. PMID: 19197721 [PubMed - indexed for MEDLINE]Related articles

Predicting durable remissions following thalidomide therapy for relapsed myeloma.

Quach H, Mileshkin L, Seymour JF, Milner A, Ritchie D, Harrison S, Westerman D, Prince HM.

Leuk Lymphoma. 2009 Feb;50(2):223-9.PMID: 19194832 [PubMed - indexed for MEDLINE]Related articles

Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices.

Worth LJ, Seymour JF, Slavin MA.

Support Care Cancer. 2009 Jul;17(7):811-8. Epub 2008 Dec 19.PMID: 19096883 [PubMed - indexed for MEDLINE]Related articles

What is the real risk of central nervous system involvement in mantle cell lymphoma?

Gill S, Seymour JF.

Leuk Lymphoma. 2008 Dec;49(12):2237-9. No abstract available. PMID: 19052969 [PubMed - indexed for MEDLINE]Related articles

Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma.

Kim PJ, Hicks RJ, Wirth A, Ryan G, Seymour JF, Prince HM, Mac Manus MP.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):740-6. Epub 2008 Nov 27.PMID: 19038505 [PubMed - indexed for MEDLINE]Related articles

Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator.

Herbert KE, Morgan S, Prince HM, Westerman DA, Wolf MM, Carney DA, Yuen K, di Iulio J, Seymour JF.

Leukemia. 2009 Feb;23(2):305-12. Epub 2008 Nov 6.PMID: 18987661 [PubMed - indexed for MEDLINE]Related articles

Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia.

Rasheed W, Flaim B, Seymour JF.

Leuk Res. 2009 Jun;33(6):861-4. Epub 2008 Nov 4. No abstract available. PMID: 18986702 [PubMed - indexed for MEDLINE]Related articles

Indolent lymphomas other than follicular and marginal zone lymphomas.

Peinert S, Seymour JF.

Hematol Oncol Clin North Am. 2008 Oct;22(5):903-40, viii. Review.PMID: 18954743 [PubMed - indexed for MEDLINE]Related articles

What is the role of 18F-fluorodeoxyglucose positron emission tomography in mantle cell lymphoma?

Gill S, Hicks RJ, Seymour JF.

Leuk Lymphoma. 2008 Sep;49(9):1653-6. Review. No abstract available. PMID: 18798097 [PubMed - indexed for MEDLINE]Related articles

Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy.

Hughes TP, Branford S, White DL, Reynolds J, Koelmeyer R, Seymour JF, Taylor K, Arthur C, Schwarer A, Morton J, Cooney J, Leahy MF, Rowlings P, Catalano J, Hertzberg M, Filshie R, Mills AK, Fay K, Durrant S, Januszewicz H, Joske D, Underhill C, Dunkley S, Lynch K, Grigg A; Australasian Leukaemia and Lymphoma Group.

Blood. 2008 Nov 15;112(10):3965-73. Epub 2008 Sep 3.PMID: 18768781 [PubMed - indexed for MEDLINE]Related articlesFree article

The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma.

Ferreri AJ, Dognini GP, Bairey O, Szomor A, Montalbán C, Horvath B, Demeter J, Uziel L, Soffietti R, Seymour JF, Ambrosetti A, Willemze R, Martelli M, Rossi G, Candoni A, De Renzo A, Doglioni C, Zucca E, Cavalli F, Ponzoni M; International Extranodal Lymphoma Study Group.

Br J Haematol. 2008 Oct;143(2):253-7. Epub 2008 Aug 10.PMID: 18699850 [PubMed - indexed for MEDLINE]Related articles

Detection of NPM1 exon 12 mutations and FLT3 - internal tandem duplications by high resolution melting analysis in normal karyotype acute myeloid leukemia.

Tan AY, Westerman DA, Carney DA, Seymour JF, Juneja S, Dobrovic A.

J Hematol Oncol. 2008 Jul 29;1:10.PMID: 18664261 [PubMed - in process]Related articlesFree article

[18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma.

Gill S, Wolf M, Prince HM, Januszewicz H, Ritchie D, Hicks RJ, Seymour JF.

Clin Lymphoma Myeloma. 2008 Jun;8(3):159-65.PMID: 18650179 [PubMed - indexed for MEDLINE]Related articles

Recommendations for the treatment of established fungal infections.

Thursky KA, Playford EG, Seymour JF, Sorrell TC, Ellis DH, Guy SD, Gilroy N, Chu J, Shaw DR.

Intern Med J. 2008 Jun;38(6b):496-520.PMID: 18588522 [PubMed - indexed for MEDLINE]Related articles

Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab.

Bishton MJ, Leahy MF, Hicks RJ, Turner JH, McQuillan AD, Seymour JF.

Ann Oncol. 2008 Sep;19(9):1629-33. Epub 2008 Jun 2.PMID: 18522934 [PubMed - indexed for MEDLINE]Related articlesFree article

Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set.

Bishton MJ, Hicks RJ, Prince HM, Ritchie DS, Wolf M, Seymour JF.

Leukemia. 2008 Dec;22(12):2259-60; author reply 2260-1. Epub 2008 May 15. No abstract available. PMID: 18480835 [PubMed - indexed for MEDLINE]Related articles

A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma.

Mitchell PL, Marlton P, Grigg A, Seymour JF, Hertzberg M, Enno A, Herrmann R, Bond R, Arthur C.

Leuk Lymphoma. 2008 May;49(5):924-31.PMID: 18464112 [PubMed - indexed for MEDLINE]Related articles

Safe treatment of a patient with CML using dasatinib after prior retinal oedema due to imatinib.

Bajel A, Bassili S, Seymour JF.

Leuk Res. 2008 Nov;32(11):1789-90. Epub 2008 May 6. No abstract available. PMID: 18462793 [PubMed - indexed for MEDLINE]Related articles

Surveillance for catheter-associated bloodstream infection in hematology units: quantifying the characteristics of a practical case definition.

Worth LJ, Black J, Seymour JF, Thursky KA, Slavin MA.

Infect Control Hosp Epidemiol. 2008 Apr;29(4):358-60.PMID: 18462148 [PubMed - indexed for MEDLINE]Related articles

A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin's lymphoma following treatment with iodine-131-rituximab radio-immunotherapy.

Bishton MJ, Hicks RJ, Westerman DA, Prince MH, Wolf M, Seymour JF.

Haematologica. 2008 May;93(5):789-90. No abstract available. PMID: 18450737 [PubMed - indexed for MEDLINE]Related articlesFree article

Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patients.

Gill S, Lane SW, Crawford J, Cull G, Joske D, Marlton P, Mollee PN, Prince HM, Seymour JF.

Ann Hematol. 2008 Sep;87(9):727-34. Epub 2008 Apr 10.PMID: 18401583 [PubMed - indexed for MEDLINE]Related articles

Impact of [18f] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma.

Wirth A, Foo M, Seymour JF, Macmanus MP, Hicks RJ.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):213-9. Epub 2008 Mar 4.PMID: 18295982 [PubMed - indexed for MEDLINE]Related articles

Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail.

Essakali S, Carney D, Westerman D, Gambell P, Seymour JF, Dobrovic A.

BMC Biotechnol. 2008 Jan 29;8:6.PMID: 18230129 [PubMed - indexed for MEDLINE]Related articlesFree article

Complete molecular response of e6a2 BCR-ABL-positive acute myeloid leukemia to imatinib then dasatinib.

Ritchie DS, McBean M, Westerman DA, Kovalenko S, Seymour JF, Dobrovic A.

Blood. 2008 Mar 1;111(5):2896-8. Epub 2007 Dec 11.PMID: 18073350 [PubMed - indexed for MEDLINE]Related articlesFree article

BCR-ABL messenger RNA levels continue to decline in patients with chronic phase chronic myeloid leukemia treated with imatinib for more than 5 years and approximately half of all first-line treated patients have stable undetectable BCR-ABL using strict sensitivity criteria.

Branford S, Seymour JF, Grigg A, Arthur C, Rudzki Z, Lynch K, Hughes T.

Clin Cancer Res. 2007 Dec 1;13(23):7080-5.PMID: 18056186 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group.

Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, Roos D, Lennard A, Devizzi L, Crabb S, Hossfeld D, Pratt G, Dell'Olio M, Choo SP, Bociek RG, Radford J, Lade S, Gianni AM, Zucca E, Cavalli F, Seymour JF; International Extranodal Lymphoma Study Group.

Ann Oncol. 2008 Feb;19(2):233-41. Epub 2007 Oct 11.PMID: 17932394 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma.

Morschhauser F, Seymour JF, Kluin-Nelemans HC, Grigg A, Wolf M, Pfreundschuh M, Tilly H, Raemaekers J, van 't Veer MB, Milpied N, Cartron G, Pezzutto A, Spencer A, Reyes F, Dreyling M.

Ann Oncol. 2008 Feb;19(2):247-53. Epub 2007 Sep 28.PMID: 17906297 [PubMed - indexed for MEDLINE]Related articlesFree article

The Late Effects Clinic in action: for survivors of childhood malignancy.

Campbell BA, Wheeler G, Seymour JF, Ritchie D, Goroncy N.

Acta Oncol. 2007;46(8):1152-8.PMID: 17851871 [PubMed - indexed for MEDLINE]Related articles

Overview of early response assessment in lymphoma with FDG-PET.

MacManus MP, Seymour JF, Hicks RJ.

Cancer Imaging. 2007;7:10-8. Review.PMID: 17766210 [PubMed - indexed for MEDLINE]Related articlesFree article

Surveillance of second cancer after previous childhood cancer treatment.

Ng SK, Mackay S, Seymour JF.

Aust Fam Physician. 2007 Aug;36(8):643-5.PMID: 17676190 [PubMed - indexed for MEDLINE]Related articlesFree article

Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk.

Worth LJ, Thursky KA, Seymour JF, Slavin MA.

Eur J Haematol. 2007 Sep;79(3):226-33. Epub 2007 Jul 26.PMID: 17655696 [PubMed - indexed for MEDLINE]Related articles

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions.

Ferreri AJ, Dognini GP, Campo E, Willemze R, Seymour JF, Bairey O, Martelli M, De Renz AO, Doglioni C, Montalbán C, Tedeschi A, Pavlovsky A, Morgan S, Uziel L, Ferracci M, Ascani S, Gianelli U, Patriarca C, Facchetti F, Dalla Libera A, Pertoldi B, Horváth B, Szomor A, Zucca E, Cavalli F, Ponzoni M; International Extranodal Lymphoma Study Group (IELSG).

Haematologica. 2007 Apr;92(4):486-92.PMID: 17488659 [PubMed - indexed for MEDLINE]Related articlesFree article

Mice lacking three myeloid colony-stimulating factors (G-CSF, GM-CSF, and M-CSF) still produce macrophages and granulocytes and mount an inflammatory response in a sterile model of peritonitis.

Hibbs ML, Quilici C, Kountouri N, Seymour JF, Armes JE, Burgess AW, Dunn AR.

J Immunol. 2007 May 15;178(10):6435-43.PMID: 17475873 [PubMed - indexed for MEDLINE]Related articlesFree article

Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure.

Ng AP, Wirth A, Seymour JF, Lee M, Hogg A, Januszewicz H, Wolf M, Prince HM, Macmanus M, Hicks RJ.

Leuk Lymphoma. 2007 Mar;48(3):596-600.PMID: 17454604 [PubMed - indexed for MEDLINE]Related articles

Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.

Gandhi MK, Moll G, Smith C, Dua U, Lambley E, Ramuz O, Gill D, Marlton P, Seymour JF, Khanna R.

Blood. 2007 Aug 15;110(4):1326-9. Epub 2007 Apr 16.PMID: 17438085 [PubMed - indexed for MEDLINE]Related articlesFree article